Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrially encoded tRNA valine (MT-TV, also called trnV or mitochondrial tRNA^Val) is a small transfer RNA found uniquely in mitochondria, where it is encoded by the mitochondrial genome at position 1602–1670 and spans 69 nucleotides in humans[1][2]. Its principal function is to deliver valine to the growing mitochondrial polypeptide chain during translation. In vertebrates, this molecule also plays a unique structural role by substituting for the missing 5S ribosomal RNA in the large subunit of the mitochondrial ribosome, facilitating proper mitochondrial protein synthesis[1][4]. MT-TV mutations are linked to several rare mitochondrial diseases, notably MELAS and Leigh's syndrome, as well as ataxia, cardiomyopathy, and other multi-system disorders, primarily through disruption of protein synthesis and energy metabolism[2][5]. No known drugs target this RNA directly, as it is not a conventional therapeutic target like receptors or enzymes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded tRNA valine (MT-TV).